Status and phase
Conditions
Treatments
About
The purpose of the study is to find out if the plasma concentration of galantamine extended release is changed when BMS-708163 is administered at the same time.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
18 participants in 3 patient groups
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal